{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:58:42Z","timestamp":1777949922870,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["874735"],"award-info":[{"award-number":["874735"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jconrel.2025.113674","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T04:04:12Z","timestamp":1743393852000},"page":"113674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine"],"prefix":"10.1016","volume":"382","author":[{"given":"Anna","family":"Dalla Piet\u00e0","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Genova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Penna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Sinigaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Vogiatzis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Barzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Pagliari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bonfante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Torrigiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasoni","family":"Sofia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranieri","family":"Verin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Tosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora","family":"Carpanese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Sommaggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Dalla Santa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaia","family":"Zuccolotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Grigoletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Pasut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rosato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113674_bb0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113674_bb0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113674_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.08.004","article-title":"The current status of COVID-19 vaccines. A scoping review","volume":"27","author":"Rueda-Fern\u00e1ndez","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2025.113674_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104742","article-title":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade","volume":"176","author":"Coutard","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jconrel.2025.113674_bb0030","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s11095-022-03323-w","article-title":"A review on immunological responses to SARS-CoV-2 and various COVID-19 vaccine regimens","volume":"39","author":"Upreti","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2025.113674_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.690621","article-title":"COVID-19 pandemic and vaccines update on challenges and resolutions","volume":"11","author":"Khan","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jconrel.2025.113674_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-021-00012-4","article-title":"Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults","volume":"1","author":"Wagner","year":"2021","journal-title":"Commun. Med."},{"key":"10.1016\/j.jconrel.2025.113674_bb0045","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41586-022-04778-y","article-title":"Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost","volume":"607","author":"Muecksch","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113674_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmolb.2021.671633","article-title":"Antibodies and vaccines target RBD of SARS-CoV-2","volume":"8","author":"Min","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jconrel.2025.113674_bb0055","article-title":"Vaccines for COVID-19: a systematic review of immunogenicity, current development, and future prospects","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.113674_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2023.04.020","article-title":"Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models","author":"Freitag","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.113674_bb0065","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","article-title":"Phase 1\u20132 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine","volume":"383","author":"Keech","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113674_bb0070","article-title":"SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses","volume":"2","author":"Mandolesi","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jconrel.2025.113674_bb0075","article-title":"Adjuvants for COVID-19 vaccines","volume":"11","author":"Castrodeza-Sanz","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2025.113674_bb0080","article-title":"The integrated consideration of vaccine platforms, adjuvants, and delivery routes for successful vaccine development","volume":"11","author":"Kozak","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2025.113674_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1459394","article-title":"Adjuvants: classification, modus operandi, and licensing","volume":"2016","author":"Apost\u00f3lico","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jconrel.2025.113674_bb0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41570-020-00244-3","article-title":"Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action","volume":"5","author":"Pifferi","year":"2021","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.jconrel.2025.113674_bb0095","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1016\/j.vaccine.2015.09.030","article-title":"Advax\u2122, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety","volume":"33","author":"Petrovsky","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.113674_bb0100","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.immuni.2016.02.004","article-title":"The vaccine adjuvant chitosan promotes cellular immunity via DNA sensor cGAS-STING-dependent induction of type I interferons","volume":"44","author":"Elizabeth","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.113674_bb0105","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1021\/acs.bioconjchem.7b00313","article-title":"Targeting CpG adjuvant to lymph node via dextran conjugate enhances antitumor immunotherapy","volume":"28","author":"Zhang","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2025.113674_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cmdc.201700646","article-title":"A synthetic MUC1 anticancer vaccine containing mannose ligands for targeting macrophages and dendritic cells","volume":"13","author":"Glaffig","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jconrel.2025.113674_bb0115","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1016\/j.vaccine.2018.07.038","article-title":"\u0392-Glucans as potential immunoadjuvants: a review on the adjuvanticity, structure-activity relationship and receptor recognition properties","volume":"36","author":"Jin","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.113674_bb0120","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41423-021-00667-y","article-title":"Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines","volume":"18","author":"Dalla Piet\u00e0","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2025.113674_bb0125","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.addr.2015.10.017","article-title":"Hyaluronan as a therapeutic target in human diseases","volume":"97","author":"Liang","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113674_bb0130","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3390\/polym10070701","article-title":"Hyaluronic acid in the third millennium","volume":"10","author":"Fallacara","year":"2018","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jconrel.2025.113674_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00150","article-title":"The where, when, how, and why of Hyaluronan binding by immune cells","volume":"6","author":"Lee-Sayer","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.113674_bb0140","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/IR:31:3:189","article-title":"Immunologic roles of Hyaluronan","volume":"31","author":"Mummert","year":"2005","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jconrel.2025.113674_bb0145","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2217\/imt.09.70","article-title":"Toll-like receptor agonists in Cancer therapy","volume":"1","author":"Adams","year":"2009","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jconrel.2025.113674_bb0150","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.4049\/jimmunol.0901683","article-title":"TLR2 engagement on dendritic cells promotes high frequency effector and memory CD4 T cell responses","volume":"183","author":"Chandran","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.113674_bb0155","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41586-020-2312-y","article-title":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice","volume":"583","author":"Bao","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113674_bb0160","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-020-2787-6","article-title":"Animal models for COVID-19","volume":"586","author":"Mu\u00f1oz-Fontela","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113674_bb0165","article-title":"SARS-CoV-2 seroconversion in humans: a detailed protocol for a serological assay, antigen production, and test setup","volume":"57","author":"Stadlbauer","year":"2020","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.jconrel.2025.113674_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.830710","article-title":"Neutralizing antibody responses to SARS-CoV-2 in recovered COVID-19 patients are variable and correlate with disease severity and receptor-binding domain recognition","volume":"13","author":"Maciola","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.113674_bb0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2016.06.033","article-title":"A site-selective hyaluronan-interferon\u03b12a conjugate for the treatment of ovarian cancer","volume":"236","author":"Montagner","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113674_bb0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/mi.2015.38","article-title":"Long-lived plasma cells are generated in mucosal immune responses and contribute to the bone marrow plasma cell pool in mice","volume":"9","author":"Lemke","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jconrel.2025.113674_bb0185","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13046-023-02628-x","article-title":"Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells","volume":"42","author":"Amaro","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113674_bb0190","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jconrel.2025.113674_bb0195","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.carbpol.2012.11.090","article-title":"Conjugation of hyaluronan to proteins","volume":"92","author":"Mero","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2025.113674_bb0200","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/mabi.201500282","article-title":"Chemical and enzymatic site specific PEGylation of hGH: the stability and in vivo activity of PEG- N -terminal-hGH and PEG-Gln141-hGH conjugates","volume":"16","author":"Grigoletto","year":"2016","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2025.113674_bb0205","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1021\/acs.biomac.3c00543","article-title":"Improving the therapeutic potential of G-CSF through compact circular PEGylation based on orthogonal conjugations","volume":"24","author":"Grigoletto","year":"2023","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2025.113674_bb0210","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0169-409X(02)00023-6","article-title":"Mono-N-terminal poly(ethylene glycol)\u2013protein conjugates","volume":"54","author":"Kinstler","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113674_bb0215","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41423-021-00667-y","article-title":"Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines","volume":"18","author":"Dalla Piet\u00e0","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2025.113674_bb0220","first-page":"1","article-title":"SARS-CoV-2 mRNA vaccines: immunological mechanism and beyond","volume":"9","author":"Bettini","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2025.113674_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-023-01116-8","article-title":"In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms","author":"Cankat","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2025.113674_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-019-0132-6","article-title":"The how\u2019s and what\u2019s of vaccine reactogenicity","volume":"4","author":"Herv\u00e9","year":"2019","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2025.113674_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-023-01024-x","article-title":"Hyaluronan as an immunological adjuvant: a novel application for an ancient molecule","author":"Carpanese","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2025.113674_bb0240","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1016\/j.vaccine.2020.09.058","article-title":"Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain fc fusion protein in mice","volume":"38","author":"Liu","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.113674_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-021-00406-4","article-title":"A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection","volume":"6","author":"Counoupas","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2025.113674_bb0250","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1016\/j.vaccine.2021.08.081","article-title":"SARS-COV-2 recombinant receptor-binding-domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1","volume":"39","author":"Law","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.113674_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-20653-8","article-title":"SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice","volume":"12","author":"Tian","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113674_bb0260","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41587-020-0577-1","article-title":"Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures","volume":"38","author":"Eroshenko","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.113674_bb0265","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1016\/j.cell.2021.05.032","article-title":"An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies","volume":"184","author":"Liu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.113674_bb0270","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41586-020-2312-y","article-title":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice","volume":"583","author":"Bao","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113674_bb0275","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(21)00183-5","article-title":"Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence","volume":"397","author":"Sabino","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.113674_bb0280","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.3201\/eid2811.220718","article-title":"SARS-CoV-2 omicron BA.1 challenge after ancestral or Delta infection in mice","volume":"28","author":"Baz","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.113674_bb0285","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijid.2023.03.029","article-title":"SARS-CoV-2 omicron variant shedding during respiratory activities","volume":"131","author":"Sen Tan","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.113674_bb0290","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/22221751.2021.2022440","article-title":"Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost, Emerg","volume":"11","author":"Ai","year":"2022","journal-title":"Microbes Infect."},{"key":"10.1016\/j.jconrel.2025.113674_bb0295","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","article-title":"SARS-CoV-2 omicron variant replication in human bronchus and lung ex vivo","volume":"603","author":"Hui","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113674_bb0300","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","article-title":"T cell responses to SARS-CoV-2 spike cross-recognize omicron","volume":"603","author":"Keeton","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113674_bb0305","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-022-00451-7","article-title":"Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge","volume":"7","author":"Wong","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2025.113674_bb0310","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41392-023-01423-6","article-title":"Intranasal booster using an omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.113674_bb0315","article-title":"Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa","volume":"376","author":"Pulliam","year":"2022","journal-title":"Science (1979)"},{"key":"10.1016\/j.jconrel.2025.113674_bb0320","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2010.10.008","article-title":"From vaccines to memory and back","volume":"33","author":"Sallusto","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.113674_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101422","article-title":"The immunology of SARS-CoV-2 infections and vaccines","volume":"50","author":"Grigoryan","year":"2020","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jconrel.2025.113674_bb0330","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925002949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925002949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:02:32Z","timestamp":1777870952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925002949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":65,"alternative-id":["S0168365925002949"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113674","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113674"}}